Yale Bulletin and Calendar

April 14, 2006|Volume 34, Number 26


BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Scientists find gene linked to drug dependence

Based on data obtained from one of the largest family sets of its kind, School of Medicine researchers have identified a genetic linkage for dependence on drugs such as heroin, morphine and oxycontin.

The lead author, Dr. Joel Gelernter, professor in the Department of Psychiatry, says the researchers recruited a sample of 393 small families, most with at least two individuals with opioid dependence. They then searched genetic signposts throughout the entire genome in an effort to identify markers that, within the same family, would show that individuals who share the illness also share marker alleles, or gene variants.

This information allowed the team to identify where genes influencing opioid dependence are located. Gelernter says the researchers found evidence of gene linkage for opioid dependence. They also found strong evidence of linkage in the family groups for the symptom cluster traits characterized by dependence on substances other than opioids, specifically, alcohol, cocaine and tobacco.

"These results provide a first basis to identify genes for opioid dependence from a genome-wide investigation," Gelernter says. "Research in the laboratory now is focused on finding specific genes that modify risk for opioid dependence."

Although environment plays a significant role, he says, it is well established that substance dependence risk is also genetically influenced. Understanding the genetic factors that influence opioid dependence risk, he adds, would represent major progress toward understanding the basic biology of the disorder.

"Once specific genes that increase or decrease risk are known, we will be in a better position to figure out exactly what the environmental factors might be and, perhaps, how they can be modified to protect people who are genetically at risk," Gelernter says.

The study was a collaborative effort involving investigators at Yale, the University of Connecticut Health Center, McLean Hospital in Boston, the Medical University of South Carolina and Boston University. The National Institute on Drug Abuse supported the study.

-- By Jacqueline Weaver


T H I SW E E K ' SS T O R I E S

It's Official. President of China to speak April 21

As HHMI Professor, Strobel will take students 'bioprospecting'

Scientists find gene linked to drug dependence

Program puts FOCUS on communication

Joan Steitz, Thomas Pollard win prestigious international prize spirit

Renowned poet W.S. Merwin to read from and discuss his work

A heroine's determination prevails in 'All's Well That Ends Well'

Event will examine how to preserve access to knowledge

Performances and workshops will explore 'theatrical bodies' . . .

Symposium on human rights will focus on memorializing atrocities

Talk, exhibit explore lessons learned from past flu outbreaks

SOM conference will examine globalization and technology

India's road to independence is topic of film, panel discussion

Dwight Hall fundraiser to include inaugural social justice award

Symposium to look at 'Success with Learning Differences'

Impact of bird-borne infections on wildlife conservation is topic of forum

Panel discussion will focus on 'Class, Race and Inequality in South Africa'

Trainer describes biker Lance Armstrong's winning ways

Tsunami Awareness Week raised funds and refocused humanitarian efforts

Campus Notes

Wangari Maathai lecture cancelled


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home